CLINICAL OUTCOMES OF INCREASED VERSUS CONVENTIONAL ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: THE RANDOMISED CONTROLLED LADI TRIAL
Reinier van Linschoten 1
Fenna Minke Jansen 2
Renske W. M. Pauwels
Lisa J. T. Smits
Femke Atsma
Wietske Kievit
Paul Boekema 3
Rachel West 4
Alexander G. L. Bodelier 5
Ingrid A. M. Gisbertz 6
Frank H. J. Wolfhagen 7
Tessa E. H. Römkens 8
Maurice W. M. D. Lutgens 9
Adriaan A. Van Bodegraven 10
Bas Oldenburg 11
Marieke Pierik 12
Maurice G. V. M. Russel 13
Rosalie C. Mallant-Hent 14
Pieter C. J. ter Borg 15
Jeroen Michiel Jansen 16
Sita Jansen 17
Adriaan C. I. T. L. Tan 18
C. Janneke van der Woude
Frank Hoentjen 19
1 Erasmus Medical Centre, Rotterdam, Netherlands
2 Radboudumc University Nijmegen Medical Centre, Nijmegen, Netherlands
3 Maxima Medical Centre, Eindhoven, Netherlands
4 Franciscus Gasthuis & Vlietland, Rotterdam
5 Amphia Hospital, Breda, Netherlands
6 Bernhoven Hospital, Uden, Netherlands
7 Albert Schweitzer Hospital, Dordrecht, Netherlands
8 Jeroen Bosch Hospital, 's-Hertogenbosch, Netherlands
9 Elisabeth Tweesteden Hospital, Tilburg, Netherlands
10 Zuyderland Medical Centre, Sittard-Geleen, Netherlands
11 Utrecht Medical Centre, Utrecht, Netherlands
12 Maastricht University Medical Centre, Maastricht, Netherlands
13 Medisch Spectrum Twente Hospital, Enschede, Netherlands
14 Flevohospital, Almere, Netherlands
15 Ikazia Hospital, Rotterdam, Netherlands
16 Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands
17 Reinier de Graaf Gasthuis, Delft, Netherlands
18 Canisius Wilhelmina Hospital, Nijmegen, Netherlands
19 University of Alberta, Edmonton, Canada
Topic
IBD, Nurses
Session
Treatment strategies in IBD
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]